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ABSTRACT 
 
This study was conducted to observe the sensitivity and resistance of status of antibiotics for respiratory tract infection 
(RTI). Throat swab culture and sensitivity report of 383 patients revealed sensitivity profiles were observed with 
amoxycillin (7.9%), penicillin (33.7%), ampicillin (36.6%), co-trimoxazole (46.5%), azithromycin (53.5%), erythromycin 
(57.4%), cephalexin (69.3%), gentamycin (78.2%), ciprofloxacin (80.2%), cephradine (81.2%), ceftazidime (93.1%), 
ceftriaxone (93.1%). Sensitivity to cefuroxime was reported 93.1% cases. Resistance was found with amoxycillin 
(90.1%), ampicillin (64.1%), penicillin (61.4%), co-trimoxazole (43.6%), erythromycin (39.6%), and azithromycin (34.7%). 
Cefuroxime demonstrates high level of sensitivity than other antibiotics and supports its consideration with patients with 
upper RTI.  
 
Keywords:  sensitivity, Respiratory tract infection (RTI) 
_______________________________________________________________________________________________ 
 
INTRODUCTION 
 
Respiratory tract infection (RTI) is considered as one of 
the major public health problems in developing countries. 
It occurs both among children and adults. It is recognized 
as the leading cause of morbidity and mortality in many 
developing countries (Baqui et al., 2007). In developing 
countries thirty percent of all patients’ consultation and 
twenty five percent of all pediatric admission are of acute 
respiratory tract infections (Rahman and Rahman, 1997)
  
and which ultimately causes 3.5 million deaths in children 
each year (Hart and Kariuki, 1998).  However, most 
infections are limited to the upper respiratory tract and 
only 5% involve the lower respiratory tract, respectively. 
Recent studies showed that Streptococcus pneumonie, 
Haemophilus influenzae and respiratory syncytial virus are 
the main causes of RTI in children (Rudan et al., 2008). 
With effective management and appropriate drug RTI can 
be managed successfully (Chowdhury et al.,2008).  
Antibiotics are commonly prescribed in treating 
common respiratory tract infections even with viral 
etiology.  As there is difficulty in establishing bacterial 
etiology at the time of prescription, antibacterial therapy of 
RTIs is usually empirical considering the presence of risk 
factors and severity of disease. In doing so, this misuse of 
antibiotics has led to the development of antibiotic-
resistant bacteria. Nowadays, antimicrobial resistance is a 
recognized problem throughout the world (Finch, 2004). 
Excessive use of antibiotics in the outpatient setting has 
contributed to the increase in antimicrobial resistance 
(Dowell and Schwartz, 1997; Diekema et al., 2000; Brown 
et al., 2003). Resistance of antimicrobials in respiratory 
tract infection is also a common health problem both for 
adult and children in Bangladesh. As in other developing 
countries, resistance to commonly used antibiotics is also 
increasing in Bangladesh due to its indiscriminate use and 
prescription. Clinical studies have shown that many 
penicillin-resistant pneumococci are also resistant to 
chloramphenicol, and cephalosporins such as cefuroxime 
and ceftriaxone, thus limiting treatment options (Sharma 
et al., 2005). The emergence of antibiotic resistance in 
common respiratory pathogens may jeopardize the 
effectiveness of empiric treatment causing increased 
morbidity and mortality from the diseases and also 
increased health cost to the patient. Accurate 
bacteriologic records of throat swab culture results may 
provide guidance for empiric therapy before sensitivity 
patterns are available. 
Therefore, knowledge of the local prevalence of 
pathogens and their antimicrobial sensitivity patterns is 
essential for clinicians in their routine work. Clinicians 
should also be aware of the sensitivity patterns in both 
neighbouring and distant areas. There is a lack of data in 
Bangladesh on commonly used antimicrobials in 
respiratory tract infections including cefuroxime sensitivity 
and/or resistance on respiratory tract pathogens. 
Therefore our study aims to determine the magnitude of 
existing problem of antibiotic resistance by observing 
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commonly used antimicrobial especially cefuroxime 
sensitivity and resistance status in respiratory tract 
pathogens.  
 
MATERIALS AND METHODS 
 
This cross-sectional survey was conducted between May 
to July 2007 to identify commonly used antimicrobials 
especially cefuroxime sensitivity and/or resistance in 
respiratory tract pathogens in Bangladesh. Clinically 
suspected outpatients of upper respiratory tract infections 
were observed for culture and sensitivity test of throat 
swabs. Throat swabs were collected from 383 cases from 
four major diagnostic centres in Dhaka city. The collected 
samples were stratified according to the growth of any 
pathogenic bacteria to evaluate sensitivity and/or 
resistance of commonly used antimicrobials. Antimicrobial 
susceptibility tests were performed on the isolates using 
disk diffusion methods. Proportion of commonly used 
antimicrobials including cefuroxime sensitivity and 
resistance was determined. 
Statistical power and sample size justification: Since 
there is no previous data on prevalence, we have 
assumed ρ=0.50; Type I error of 0.05. Finally the sample 
size was 383. This sample size allowed having an 
optimum number of patients in each centre. 
 
RESULTS 
 
As shown in Table 1, a total of 384 clinically suspected 
cases of upper respiratory tract infections, among them 
only 383 throat swab samples were considered for final 
analysis. Mean age of the patients was 23 years and half 
of them were children and others were teenagers and 
adults. Among all the samples, one among every four 
cases showed growth of any pathogenic bacteria in 
culture and sensitivity test. 
 
Table 1:  Distribution of bacterial growth among all   
participants. Cross sectional study, Dhaka, 
Bangladesh 
 
Bacterial growth  N  Percentage (%) 
Growth 101  26.3 
No growth  282  73.7 
Total 383  100.0 
 
According to the report of culture and sensitivity test, 
the isolated pathogens in the aggregates were β hemolytic 
streptococci (28.7%), Klebsiella pneumoniae (28.7%), 
Staphylococci (25.7%), Pseudomonas (4%), E. coli (2%), 
Pneumococcus (2%) (Table 2). 
 
 Among the commonly used antimicrobials in URTI, 
sensitivity profiles were observed with amoxycillin (7.9%), 
penicillin (33.7%), ampicillin (36.6%), co-trimoxazole 
(46.5%), azithromycin (53.5%), erythromycin (57.4%), 
cephalexin (69.3%), gentamycin (78.2%), ciprofloxacin 
(80.2%), cephradine (81.2%), levofloxacin (86.2%), 
ceftazidime (93.1%), ceftriaxone (93.1%). Sensitivity to 
cefuroxime was reported in 93.1% cases. However, 
antimicrobial resistance was observed most against 
amoxycillin (90.1%). Resistance to others was as follows, 
penicillin (61.4%), ampicillin (64.1%), co-trimoxazole 
(43.6%), erythromycin (39.6%), and azithromycin (34.7%) 
(Table 3). 
 
Table 2:  Bacterial isolates in culture 
 
Isolated pathogens  N  Percentage (%) 
β hemolytic streptococci  29 28.7 
Klebsiella pneumoniae  29 28.7 
Pseudomonas  4 4.0 
Staphylococci  26 25.7 
Pneumococcus  2 2.0 
E. coli  2 2.0 
Total 92  91.1 
Misssing 9  8.9 
Total 101  100.0 
 
 
Table 3: Commonly used antimicrobial sensitivity and 
resistance status in URTI. Cross sectional study, 
Dhaka , Bangladesh 
 
Antibiotics  Sensitivity (%)  Resistance (%) 
Amoxycillin 7.9  90.1 
Penicillin 33.7  64.4 
Ampicillin 36.6  61.4 
Co-trimoxazole 46.5  43.6 
Azithromycin 53.5  34.7 
Erythromycin 57.4  39.6 
Cephalexin 69.3  26.7 
Gentamycin 78.2 19.8 
Ciprofloxacin 80.2  9.9 
Cephradine 81.2 15.8 
Levofloxacin 86.2  11.9 
Ceftazidime 93.1  4.0 
Ceftriaxone 93.1 4.0 
Cefuroxime 93.1 6.9 
 
 
Among 383 reports, 101 (26.3%) were growth 
positive, while 282 (73.4%) did not show any growth of 
pathogenic bacteria. Of the respondents, about 93.1% 
cases reported sensitivity to cefuroxime (Figure 1). 
 
DISCUSSION 
 
Antimicrobial drugs are an important resource that must 
be conserved for proper use. To accomplish this requires 
knowledge of the dimension of the problem and early 
warnings of the emergence of resistant isolates. Antibiotic 
resistant bacteria are associated with the failure of 
treatment and increased mortality and morbidity. Many 
bacteria (for example, β hemolytic streptococci,  K. 
pneumoniae, Staphylococci) still remaining predictably  
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Figure 1:   Cefuroxime sensitivity in culture & sensitivity 
test of throat swabs  
 
 
sensitive to a few of the routinely available antimicrobial 
drugs. This study result demonstrates that most of the 
bacterial isolates in culture and sensitivity of throat swabs 
are sensitive to cefuroxime (93.1%). In a study at Peshwar 
Pakistan found, amoxicillin as the best cost effective drug 
followed by clarithromycin and cefuroximine in the 
treatment of RTI (Aurangzeb and Hameed, 2003). A study 
was carried out in the largest children hospital in 
Bangladesh concluded that trimethoprim 
suphamethoxazole resistance is very common in 
treatment of RTI for children under the age of five (Baqui 
et al., 2007). However, sensitivity to penicillin, ampicillin, 
amoxycillin, co-trimoxazole, erythromycin, azithromycin 
has continued to fall and precludes their use in empiric 
treatment. Among them, a high level of resistance was 
observed to amoxycillin (90.1%). Perhaps this occurred, 
as the study centres were in urban setting and the 
patients have more access to the doctors in comparison to 
others parts in the country.  
The increasing resistance of these antimicrobials in 
upper respiratory tract pathogens is of great concern; our 
study had a high level of resistance to some of these 
commonly used antimicrobial drugs. The high prevalence 
of resistant bacteria seems to be related to irrational 
antimicrobial usage. A meta analysis concluded , oral 
cephalosporin is significantly more effective than oral 
pencillin in the treatment of RTI (Casey and Pichichero, 
2004). In Bangladesh the use of antimicrobial drugs in 
URTI is uncontrolled; antibiotics can be purchased in 
pharmacies, general stores, and even market stalls. Many 
of the medical practitioners prescribe antibiotics to these 
patients on the basis of symptoms alone. Selection of an 
anti-infective agent regimen for the treatment of upper 
respiratory tract pathogens should be based on the drug’s 
spectrum of activity as well as the regimen’s bacteriologic 
and clinical efficacy, potential adverse effects, ease of 
administration and patient compliance, and cost. Patients 
sometimes expect an antibiotic for an acute respiratory 
infection; health care professionals strive for patient 
satisfaction to some extend. Patients sometimes insist 
physicians to prescribe antibiotics without any specific 
reason. In studies carried out in Bangladesh, it was 
observed in many cases that physicians are requested 
either by patients or their attendants to prescribe antibiotic 
as they perceive that it will enhance quick recovery. If the 
diagnosis is a viral illness, the physician needs to have a 
contingency plan to explain to the patient why an antibiotic 
will not be prescribed. The different international 
authorities have endorsed a campaign to promote 
appropriate antibiotic use for the treatment of acute 
respiratory tract infections in adults and children. It is also 
documented that Clinical Practice Guidelines providing 
evidence-based recommendations to be practiced by the 
physicians for the proper management of patients 
(Gonzales et al., 2001). These provide practical strategies 
for limiting antibiotic use to the patients with URTI. 
Furthermore, it is required to restrict the sale of antibiotics 
without prescription, to use antibiotics more judiciously in 
hospitals by intensive teaching of the principles of the use 
of antibiotics (Kim and Park, 1998). There must also be 
greater regulation of the use of antibiotics; this should be 
accompanied by strategies to educate the public and 
doctors on the appropriate use of antibiotics in URTI (Hart 
and Kariuki, 1998).   
The survey shows an increased level of resistance 
among the respiratory pathogens against commonly used 
antimicrobials in upper respiratory tract infections in 
Bangladesh. On the other hand few of the antimicrobial 
drugs still remain highly sensitive to the pathogens. 
Among them cefuroxime, ceftazidime and ceftriaxone 
demonstrate high level of sensitivity on respiratory tract 
pathogens. This study supports use of cefuroxime as 
appropriate in the patients with URTI. Morover cefuroxime 
is found safe during pregnancy (Benyamini et al., 2005). 
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